Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2011-09-30
2017-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE, AIMS \& HYPOTHESIS The investigators purpose is to evaluate whether a supervised cardiac rehabilitation program improves the objective physical capacity and quality of life (QoL) of patients after AVR due to AS, and compare this to patients training by their own. The investigators hypothesize that supervised exercise training may be a more efficient way of rehabilitating these patients.
DESIGN This is a controlled randomized clinical trial comparing 12 weeks of supervised exercise training 3 times per week to home-based training based upon public health recommendations of minimum level of physical activity.
SIGNIFICANCE \& IMPLEMENTATION Positive results would support that an organized program of exercise training improves physical capacity and QoL in AS patients following AVR with potential benefit for both patients and society.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supervised Exercise Training
12 weeks of 40 min aerobic bicycle ergometer exercise 3 times per week.
Aerobic Exercise Training
12 weeks of endurance training, 40 minutes, 3 times per week on ergometer bicycle.
Physical Activity Recommendations
Written and verbal information on minimal level of physical activity recommended.
Physical Activity Recommendations
Written and verbal information on minimal level of physical activity recommended.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic Exercise Training
12 weeks of endurance training, 40 minutes, 3 times per week on ergometer bicycle.
Physical Activity Recommendations
Written and verbal information on minimal level of physical activity recommended.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Geographical residence no further from hospital than permitting visit to Supervised Exercise Training 3 times per week
Exclusion Criteria
* Other surgical intervention at time of valve replacement
* Age under 18 years
* Symptomatic lung disease
* Any disability or disease hampering participation in exercise training
* Cannot communicate with spoken Swedish
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Linkoeping University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kristofer Hedman
Principal Investigator, BSc, Physiotherapist, PhD-student
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eva Nylander, PhD
Role: STUDY_DIRECTOR
Linkoeping University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heart and Medicine Center, Linköping University Hospital
Linköping, Östergötland County, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RASP
Identifier Type: -
Identifier Source: org_study_id